Phase III Study to Evaluate Temsirolimus Compared With Investigator’s Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Hess, G; Herbrecht, R; Romaguera, J (JCO, 2009)
et al.